Balancing Process and Red Tape in a Small Professional Services Company

Standard operating procedures (SOPs) aren’t always glamorous, but they can be vitally important to ensuring a healthy and efficient organization. But how do you know when too much process has turned your organization into a bureaucracy, where employees are ignoring independent decision making in favor of blindly adhering to some steps in a training manual? […]

Read More

Driving the Right Decisions: Three Steps

Marketing Research provides the greatest benefit to internal stakeholders when it helps them “predict the future.” Predicting the future can involve answering several very different kinds of questions. For example, “How should I develop this asset?” “Should I acquire a competitor?” “Which message or campaign will achieve the highest market share?” and “Who in my […]

Read More

So Why Do We Need Surveys Anyway?

Within the sphere of marketing research activities today, few have lower prestige than the simple survey. If you read the blogosphere, you see questions asking whether primary marketing research will be dead in 10 years (or maybe 5), whether Big Data will eliminate the need for surveys completely, and whether traditional “data collection” has a […]

Read More

Failure is not an option

In his most recent post, RG+A’s CEO Roger Green discussed the marketing research industry’s identity crisis. Regardless of what we call it – business intelligence, customer advocacy, decision support – the fact of the matter is that the needs and expectations of marketing research’s customers have evolved, and we as an industry need to evolve […]

Read More

Telling Suppliers Your Project Budget

There seems to be an unwritten rule that says you should never share your project budget with a market research supplier. It probably derives from a concern that letting suppliers know your budget is an invitation for them to take advantage of you. You will end up with three bids all on or near your […]

Read More

Implications for ASCO’s cancer drug scorecard

A recent article in the Journal of Clinical Oncology, presented at the 2015 ASCO conference, has put forward a “scorecard” for judging oncology medications to be used by physicians and patients. This scorecard was put together by an ASCO task force and is the culmination of over 8 years of work. The task force’s objective […]

Read More

The Four-Month Black Hole

Last week, I called a client who serves of CEO of a publicly traded company to discuss a study we had recently completed.  With study results and models in hand, he was in the process of negotiating a major acquisition.  He stressed how helpful our work was in guiding him to a “win-win” posture. When […]

Read More